• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
  • About Us
  • Contact Us
  • Billing Portal
SPRINT® PNS System

SPR Therapeutics

SPRINT PNS System

  • Product
  • For Physicians
    • Clinical Outcomes & References
    • Implant Procedure Videos
    • Video Resources
    • SPRcare Reimbursement
    • Important Safety Information
    • MRI Safety Information
    • Promotional Marketing Toolkit
  • For Patients
    • Patient Stories
    • Patient Resources
    • Recursos para pacientes
    • MicroLead™ Safety
    • MRI Safety Information
  • Clinical Trials
  • News & Events
    • News
    • Events
    • Press Room
  • Careers

Clinical Outcomes & References

Clinically proven.

The SPRINT PNS System has been studied extensively for low back pain, shoulder pain, post-amputation pain, and chronic and acute post-operative pain, and is indicated for use up to 60 days.

Over 70% of patients reported significant & sustained pain relief

SPRINT system-related peer-reviewed publications, presentations, and collected data.

  • Sheth SJ, Kissoon NR, Pingree MJ, Dicerson DM, Ottestad E, Zurn CA, Crosby ND, Boggs JW. Real-world evidence of significant pain relief following 60-day stimulation of occipital nerves for the treatment of chronic pain. As presented at the American Society of Regional Anesthesia and Pain Medicine (ASRA), November, 2022. View Poster Here.
  • Shah SS, Manvar A, Shah N, Erosa S, Zurn CA, Crosby ND, Boggs JW. Significant and sustained relief of shoulder pain following 60-day PNS treatment: A real-world retrospective review. As presented at the American Society of Regional Anesthesia and Pain Medicine (ASRA), November, 2022. View Poster Here.
  • Huntoon MA, Crosby ND, Swan BD, deBock MG, Boggs JW. Histological evaluation of tissue ingrowth in open-coil percutaneous 60-day peripheral nerve stimulation leads. As presented at the American Society of Regional Anesthesia and Pain Medicine (ASRA), November, 2022. View Poster Here.
  • RD Mattie, MD, JA Kost, MD, EP Washabaugh, MD, DD Lester, MD, CA Zurn, MS, ND Crosby, PhD, JW Boggs, PhD. Pain relief following 60-day peripheral nerve stimulation (PNS) of the cervical medial branch nerves: a real-world retrospective review. As presented at Pacific Spine Pain Society (PSPS) Annual (2022) Conference, September 2022. View Poster Here.
  • Strand N, D’Souza RS, Hagedorn JM, Pritzlaff S, Sayed D, Azeem N, Abd-Elsayed A, Escobar A, Huntoon MA, Lam CM, Deer TR. Evidence-Based Clinical Guidelines from the American Society of Pain and Neuroscience for the Use of Implantable Peripheral Nerve Stimulation in the Treatment of Chronic Pain, Journal of Pain Research, August 2022.
  • Gilmore CA, Desai MJ, Hopkins TJ, Li S, DePalma MJ, Deer TR, Cohen SP, McGee MJ, Boggs JW Durability of Relief with Percutaneous Medial Branch PNS for the Treatment of Chronic Axial Low Back Pain. As presented at American Society of Pain and Neuroscience (ASPN) Fourth Annual Conference, July 2022. View Poster Here.
  • Slavin KV, Huntoon MA, Hagedorn JM, Crosby ND, Boggs JW. Retrospective review of real-world pain and quality of life outcomes resulting from 60-day PNS treatment for chronic pain. As presented at American Society for Stereotactic and Functional Neuorsurgery (ASSFN) Biennial Meeting, June 2022. View Poster Here.
  • Pingree MJ, Hurdle MGB, Spinner DA, Valimahomed A, Crosby ND, Boggs JW. Real-world evidence of sustained improvement following 60-day peripheral nerve stimulation treatment for pain: a cross-sectional follow-up survey, Pain Management, May 2022
  • Naidu R, Li S, Desai MJ, Sheth S, Crosby ND, Boggs JW, 60-Day PNS Treatment May Improve Identification of Delayed Responders and Delayed Non-Responders to Neurostimulation for Pain Relief, Journal of Pain Research, March 2022.
  • Gulati A, Deer TR, Ottestad E, Erdek M, Spinner D, Staats P. Understanding the role of patient preference in the treatment algorithm for chronic low back pain: results from a survey-based study, Pain Management, September 2021.
  • Gilmore CA, Desai MJ, Hopkins TJ, Li S, DePalma MJ, Deer TR, Grace W, Burgher AH, Sayal PK, Amirdelfan K, Cohen SP, McGee MJ, Boggs JW, Treatment of Chronic Axial Back Pain with 60-day Percutaneous Medial Branch PNS: Primary Endpoint Results from a Prospective, Multicenter Study, PAIN Practice, July 2021.
  • Ilfeld BM, Plunkett A, Vijjeswarapu AM, Hackworth R, Dhanjal S, Turan A, Cohen SP, Eisenach JC, Griffith S, Hanling S, Sessler DI, Mascha EJ, Yang D, Boggs JW, Wongsarnpigoon A, Gelfand H Percutaneous, Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Pain: A Randomized, Sham-controlled Pilot Study, Anesthesiology, April 2021.
  • Deer TR, Eldabe S, Falowski SM, Huntoon MA, Staats PS, Cassar IR, Crosby ND, Boggs JW. Peripherally-Induced Reconditioning of the CNS: Proposed Mechanisms for Sustained Relief Following 60-Day Percutaneous PNS Treatment, Journal of Pain Research, 12 March 2021 Volume 2021:14 Pages 721-736.
  • Deer TR, Gilmore CA, Desai MJ, Li SC, DePalma MJ, Hopkins TJ, Burgher AH, Spinner DA, Cohen SP, McGee MJ, Boggs JW. Percutaneous Peripheral Nerve Stimulation of the Medial Branch Nerves for the Treatment of Chronic Axial Back Pain in Patients After Radiofrequency Ablation, Pain Medicine, 2021; pnaa432
  • Gulati A, Desai MJ, Rosenow JM, Cohen SP, Crosby ND, Boggs JW. Sustained Pain Relief Following 60-Day Percutaneous PNS in Majority of Patients: Review of Clinical Evidence, 2021. View Poster Here.
  • Gulati A, Desai MJ, Rosenow JM, Cohen SP, Crosby ND, Boggs JW. A Review of Clinical Evidence for Percutaneous Peripheral Nerve Stimulation Demonstrating Sustained Relief of Chronic Pain in a Majority of Subjects. As presented at 2020 American Society for Pain and Neuroscience (ASPN). View Poster here.
  • Gilmore, C, Kapural, L, Hopkins T, Desai M, Li S, DePalma M, Deer TR, Burgher A, McGee M, Boggs J. Reductions in Opioid Consumption Reported among Chronic Low Back Pain Patients Following Percutaneous Peripheral Nerve Stimulation (PNS) of the Medial Branch Nerves for up to 60 Days. As presented at American Society of Regional Anesthesia and Pain Medicine November 2019.
  • Gilmore CA, Kapural L, McGee M, Boggs JW. Percutaneous Peripheral Nerve Stimulation for Chronic Low Back Pain: Prospective Case Series with One Year of Sustained Relief following Short‐term Implant. Pain Pract. 2019 Nov 6.
  • Gilmore CA, Ilfeld BM, Rosenow JM, Li S, Desai MJ, Hunter CW, Rauck RL, Nader A, Mak J, Cohen SP, Crosby ND, Boggs JW. Percutaneous 60-day Peripheral Nerve Stimulation Implant Provides Sustained Relief of Chronic Pain Following Amputation: 12-month Follow-Up of a Randomized, Double-Blind, Placebo-Controlled Trial. Regional Anesthesia and Pain Medicine, 2020; 45:44-51. View Poster Here. 
  • Gilmore CA, Kapural L, McGee M, Boggs JW. Percutaneous Peripheral Nerve Stimulation for Chronic Low Back Pain: Prospective Case Series with One Year of Sustained Relief following Short‐term Implant. Pain Pract. 2019
  • Cohen S, Gilmore C, Kapural L, Hopkins T, Desai M, DePalma M, Li S, Burgher A, Deer T, Plunkett T, McGee M, Boggs J. Reductions in Opioid Consumption with Percutaneous Medial Branch Peripheral Nerve Stimulation for Chronic Low Back Pain as presented at the Military Health Research Symposium August 21, 2019, Kissimmee, FL.
  • Ilfeld BM, Ball ST, Cohen SP, Hanling SR, Fowler IM, Wongsarnpigoon A, Boggs JW. Percutaneous Peripheral Nerve Stimulation to Control Postoperative Pain, Decrease Opioid Use, and Accelerate Functional Recovery Following Orthopedic Trauma. Mil Med. 2019 Mar 1;184(Supplement_1):557-564.
  • Physician Survey Data from PNS Leadership Forum, Scottsdale AZ, December 2019. Data on file SPR Therapeutics.
  • Patient Preference Survey, 2019. Data on file SPR Therapeutics.
  • Cohen SP, Gilmore CA, Kapural L, Hanling S, Plunkett A, McGee MJ, Boggs JW. Percutaneous Peripheral Nerve Stimulation for Pain Reduction and Improvements in Functional Outcomes in Chronic Low Back Pain. Mil Med. 2019 Mar 1;184(Supplement_1):537-541.
  • Cohen SP, Gilmore CA, Rauck RL, Lester DD, Trainer RJ, Phan T, Kapural L, North JM, Crosby ND, Boggs JW. Percutaneous Peripheral Nerve Stimulation for the Treatment of Chronic Pain Following Amputation. Military Medicine, 2019:10.1093/milmed/usz114.
  • Christopher A. Gilmore, MD et al, Percutaneous Peripheral Nerve Stimulation for the Treatment of Chronic Neuropathic Post-Amputation Pain: A Multi-Center Randomized Placebo-Controlled Trial. Regional Anesthesia and Pain Medicine, 2019.
  • Ilfeld, B.M., J.J.t. Finneran, R.A. Gabriel, E.T. Said, P.L. Nguyen, W.B. Abramson, B. Khatibi, J.F. Sztain, M.W. Swisher, P. Jaeger, D.C. Covey, M.J. Meunier, E.R. Hentzen, and C.M. Robertson, Ultrasound-guided percutaneous peripheral nerve stimulation: neuromodulation of the suprascapular nerve and brachial plexus for postoperative analgesia following ambulatory rotator cuff repair. A proof-of-concept study. Reg Anesth Pain Med, 2019.
  • Wilson, Richard D., et al. Fully Implantable Peripheral Nerve Stimulation for Hemiplegic Shoulder Pain: A Multi‐Site Case Series With Two‐Year Follow‐Up. Neuromodulation: Technology at the Neural Interface 21.3 (2018): 290-295.
  • Gilmore CA, Kapural L, McGee MJ, Boggs JW. Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Chronic Low Back Pain Provides Sustained Relief. Neuromodulation. 2018 Oct 3.
  • Ilfeld, Brian M., et al., Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: Neuromodulation of the Sciatic Nerve for Postoperative Analgesia Following Ambulatory Foot Surgery, a Proof-of-Concept Study. Regional Anesthesia and Pain Medicine 2018. 43(6): p. 580–589.
  • Ilfeld B.M., Ball S.T., Gabriel R.A., Sztain J.F., Monahan A.M., Abramson W.B., Khatibi B., Said E.T., Parekh J., Grant S.A., Wongsarnpigoon A., Boggs J.W. 2018. A Feasibility Study of Percutaneous Peripheral Nerve Stimulation for the Treatment of Postoperative Pain Following Total Knee Arthroplasty. Neuromodulation; 22 (5), 653-660
  • Shellock, FG, Zare A, Ilfeld BM, Chae J, Strother, RB (2018).Vitro Magnetic Resonance Imaging Evaluation of Fragmented, Open-Coil, Percutaneous Peripheral Nerve Stimulation Leads. Neuromodulation Volume 21, Issue 3, 276-283.
  • Gilmore, C.A., Kapural, L, McGee, M.J., Boggs, J.W. (2018). Minimally invasive percutaneous peripheral nerve stimulation (PNS) reduces pain and disability in chronic low back pain. World Congress on Regional Anesthesia and Pain Medicine (ASRA), 2018.
  • Gilmore C.A., Ilfeld B.M., Rosenow J.M., Li S., Desai M.J., Hunter C.W., Nader A., Mak J., Rauck R.L., Kapural L., Crosby N.D., Boggs J.W. (2018). Percutaneous peripheral nerve stimulation (PNS) for the treatment of chronic neuropathic post-amputation pain: Initial results from a multicenter, randomized, placebo-controlled study. Napa Pain Conference.
  • Staats, P. Neuromodulation as an Alternative to Opioid in the Evolving Health Care Crisis – A Supplement to Pain Medicine News (2017)
  • lIfeld, B. M., et al., Ultrasound-guided percutaneous peripheral nerve stimulation for analgesia following total knee arthroplasty Journal of Orthopaedic Surgery and Research (2017)
  • Kapural L, Gilmore CA, Chae J, et al. Percutaneous Peripheral Nerve Stimulation for the Treatment of Chronic Low Back Pain: Two Clinical Case Reports of Sustained Pain Relief. Pain Pract. 2017.
  • Ilfeld, B.M., Gilmore, C.A., Grant, S.A., Bolognesi, M. P., Del Gaizo, D.J., Wongsarnpigoon, A., & Boggs, J.W. (2017). Ultrasound-guided percutaneous peripheral nerve stimulation for analgesia following total knee arthroplasty: a prospective feasibility study. Journal of orthopaedic surgery and research, 12(1), 4.
  • Ilfeld, B.M. and S.A. Grant, Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation for Postoperative Analgesia: Could Neurostimulation Replace Continuous Peripheral Nerve Blocks? Reg Anesth Pain Med, 2016.
  • Ilfeld, B. M., et al., Infection Rates of Electrical Leads Used for Percutaneous Neurostimulation of the Peripheral Nervous System. Pain Pract. (2016)
  • Ilfeld, B.M., Grant, S.A., Gilmore, C.A., Chae, J., Wilson, R.D., Wongsarnpigoon, A., & Boggs, J.W. (2016). Neurostimulation for Postsurgical Analgesia: A Novel System Enabling Ultrasound-guided Percutaneous Peripheral Nerve Stimulation. Pain Practice, 17(7), 892-901.
  • Nguyen, V.Q., et al., Fully implantable peripheral nerve stimulation for the treatment of hemiplegic shoulder pain: a case report. Am J Phys Med Rehabil, 2015. 94(2): p. 146-53.
  • Rauck, R.L., Cohen, S.P., Gilmore, C.A., North, J.M., Kapural, L., Zang, R.H., & Boggs, J.W. (2014). Treatment of post-amputation pain with peripheral nerve stimulation. Neuromodulation: Technology at the Neural Interface, 17(2), 188-197.
  • Wilson, R.D., Harris, M. A., Gunzler, D.D., Bennett, M.E., & Chae, J. (2014). Percutaneous peripheral nerve stimulation for chronic pain in subacromial impingement syndrome: a case series. Neuromodulation: Technology at the Neural Interface, 17(8), 771-776.
  • Wilson, R.D., Gunzler, D.D., Bennett, M.E., & Chae, J. (2014). Peripheral nerve stimulation compared with usual care for pain relief of hemiplegic shoulder pain: a randomized controlled trial. American journal of physical medicine & rehabilitation/Association of Academic Physiatrists, 93(1), 17.
  • Chae, J., Wilson, R.D., Bennett, M.E., Lechman, T. E., & Stager, K.W. (2013). Single-lead percutaneous peripheral nerve stimulation for the treatment of hemiplegic shoulder pain: a case series. Pain practice, 13(1), 59-67.
  • Rauck, R.L., et al., Peripheral nerve stimulation for the treatment of post-amputation pain–a case report. Pain practice: the official journal of World Institute of Pain, 2012. 12(8): p. 649-55.
  • Stolzenberg, D., G. Siu, and E. Cruz, Current and future interventions for glenohumeral subluxation in hemiplegia secondary to stroke. Top Stroke Rehabil, 2012. 19(5): p. 444-56.
  • Wilson, R.D., et al., Single-lead percutaneous peripheral nerve stimulation for the treatment of hemiplegic shoulder pain: a case report. Arch Phys Med Rehabil, 2011. 92(5): p. 837-40.
  • Chae, J., et al., Intramuscular electrical stimulation for shoulder pain in hemiplegia: does time from stroke onset predict treatment success? Neurorehabil Neural Repair, 2007. 21(6): p. 561-7.
  • Chae, J., David, T.Y., Walker, M.E., Kirsteins, A., Elovic, E.P., Flanagan, S.R., & Fang, Z.P. (2005) Intramuscular electrical stimulation for hemiplegic shoulder pain: a 12-month follow-up of a multiple-center, randomized clinical trial. American journal of physical medicine & rehabilitation, 84(11), 832-842.
  • Renzenbrink, G.J. and I.J. MJ, Percutaneous neuromuscular electrical stimulation (P-NMES) for treating shoulder pain in chronic hemiplegia. Effects on shoulder pain and quality of life. Clin Rehabil, 2004. 18(4): p. 359-65.
  • Yu, D.T., et al., Intramuscular neuromuscular electric stimulation for poststroke shoulder pain: a multicenter randomized clinical trial. Arch Phys Med Rehabil, 2004. 85(5): p. 695-704.
  • Chae, J., D. Yu, and M. Walker, Percutaneous, intramuscular neuromuscular electrical stimulation for the treatment of shoulder subluxation and pain in chronic hemiplegia: a case report. Am J Phys Med Rehabil, 2001. 80(4): p. 296-301.
  • Yu, D.T., Chae, J., Walker, M.E., & Fang, Z. P. (2001). Percutaneous intramuscular neuromuscular electric stimulation for the treatment of shoulder subluxation and pain in patients with chronic hemiplegia: a pilot study. Archives of physical medicine and rehabilitation, 82(1), 20-25.
SPRINT® PNS System

22901 Millcreek Blvd, Suite 500
Cleveland, OH 44122
(844) 378-9108 Phone
(216) 803-0777 Fax

Top Work Places 2022

Quick Links

  • Product
  • For Physicians
  • For Patients
  • Clinical Trials
  • News & Events
  • Careers
  • About Us
  • Contact Us

Legal Links

  • Privacy Statement
  • Terms of Use
  • CPRA Requests
  • Important Safety Information
  • Compliance
  • FCOI Policy
  • Product Terms & Conditions
  • Patent Information

Recent News Headlines

SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System

Sprint Regional Lab Fluoro Only – Boston

Sprint Regional Lab – Boston

SPRINT PNS Regional Lab & APP Program: Kansas City

The SPRINT PNS System is indicated for up to 60 days for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves. Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.

View References for support of all claims.

The SPRINT® PNS System, MicroLead™, OnePass Introducer™, Rethink Your Pain Strategy™, Outsmart Pain™, Sustained Pain Relief Starts Here™, Life. Get Back to It.™ and SPR® are registered or common law trademarks of SPR Therapeutics, Inc.


Copyright © 2023 SPR Therapeutics. All Rights Reserved.

This website is intended only for US and Canadian residents 18 years of age and older. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept
Powered by CookieYes Logo